Public access to protocols of contemporary cancer randomized clinical trials

Access to randomized clinical trial (RCT) protocols is necessary for the interpretation and reproducibility of the study results, but protocol availability has been lacking. We determined the prevalence of protocol availability for all published cancer RCTs in January 2020. We found that only 36.1%...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, Christopher, Mell, Loren, Lee, Nancy, Zakeri, Kaveh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237482/
https://www.ncbi.nlm.nih.gov/pubmed/34176506
http://dx.doi.org/10.1186/s13063-021-05382-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237482/
https://www.ncbi.nlm.nih.gov/pubmed/34176506
http://dx.doi.org/10.1186/s13063-021-05382-7

Ejemplares similares